Rosiglitazone Attenuates Atrial Structural Remodeling and Atrial Fibrillation Promotion in Alloxan-Induced Diabetic Rabbits
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rosiglitazone Attenuates Atrial Structural Remodeling and Atrial Fibrillation Promotion in Alloxan-Induced Diabetic Rabbits
Authors
Keywords
-
Journal
Cardiovascular Therapeutics
Volume 32, Issue 4, Pages 178-183
Publisher
Wiley
Online
2014-05-09
DOI
10.1111/1755-5922.12079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits
- (2013) Huaying Fu et al. Cardiology Journal
- Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation
- (2013) Changle Liu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: A review of current evidence
- (2012) Tong Liu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus
- (2011) J. Gu et al. EUROPACE
- Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes
- (2011) Tze-Fan Chao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- PPAR-γ Activator Pioglitazone Prevents Age-Related Atrial Fibrillation Susceptibility by Improving Antioxidant Capacity and Reducing Apoptosis in a Rat Model
- (2011) DONGZHU XU et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Atrial fibrillation
- (2011) Gregory YH Lip et al. LANCET
- Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats
- (2010) Osamu Kume et al. HEART RHYTHM
- Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
- (2010) Volker Rudolph et al. NATURE MEDICINE
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Inflammation: Another Potential Mechanism Between Diabetes Mellitus and Atrial Fibrillation
- (2008) Tong Liu et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of Association Between C-Reactive Protein and Immediate Success of Electrical Cardioversion in Persistent Atrial Fibrillation
- (2008) Tong Liu et al. AMERICAN JOURNAL OF CARDIOLOGY
- AGEs-RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat
- (2008) TAKESHI KATO et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure
- (2007) Masayuki Shimano et al. HEART RHYTHM
- Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy
- (2007) Panagiotis Korantzopoulos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The potential role of thiazolidinediones in atrial fibrillation
- (2007) Tong Liu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search